​

Funding Round

Series B - Nimbus Therapeutics

Series B - Nimbus Therapeutics

Investment Firm

Overview

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Announced Date

Mar 19, 2015

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Lightstone Ventures

Lightstone Ventures

Lightstone Ventures is a early_stage_venture and late_stage_venture and private_equity and venture firm.

Pfizer Venture Investments

Pfizer Venture Investments

Pfizer Venture Investments is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorLilly Ventures
Participant InvestorSR One
Participant InvestorLightstone Ventures
Participant InvestorBill Gates
Participant InvestorAtlas Venture

Round Details and Background

Nimbus Therapeutics raised $43000000 on 2015-03-19 in Series B

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 19, 2015
Series B - Nimbus Therapeutics
6-43.0M
Apr 29, 2010
Seed Round - Nimbus Therapeutics
2-3.5M
Jun 28, 2011
Series A - Nimbus Therapeutics
4-24.0M
Mar 10, 2011
Seed Round - Nimbus Therapeutics
3-1.5M

Recent Activity

There is no recent news or activity for this profile.